INCYTE CORP
For the period ended Sep 30, 2024. Filed Oct 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 29, 2024
INCY$120.30-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(unaudited, in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net (loss) income | $(168,597) | $396,520 |
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 66,515 | 60,898 |
| Stock-based compensation | 194,340 | 155,899 |
| Deferred income taxes | (85,609) | (92,919) |
| Other, net | (4,824) | (543) |
| Realized and unrealized gain on equity investments | (126,206) | (9,839) |
| Loss on change in fair value of acquisition-related contingent consideration | 23,847 | 14,144 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (14,893) | (12,384) |
| Prepaid expenses and other assets | (55,381) | (62,081) |
| Inventory | (93,352) | (77,193) |
| Accounts payable | 69,109 | (138,135) |
| Accrued and other liabilities | 149,170 | 114,391 |
| Net cash (used in) provided by operating activities | (45,881) | 348,758 |
| Cash flows from investing activities: | ||
| Purchase of long term investments | — | (10,000) |
| Sale of equity investments | 282,866 | 45 |
| Capital expenditures | (68,879) | (30,219) |
| Payments for intangible assets | (13,900) | (15,000) |
| Purchases of marketable securities | (228,986) | (222,228) |
| Sale and maturities of marketable securities | 207,881 | 224,225 |
| Net cash provided by (used in) investing activities | 178,982 | (53,177) |
| Cash flows from financing activities: | ||
| Repurchases of common stock | (2,004,790) | — |
| Proceeds from issuance of common stock under stock plans | 16,242 | 28,319 |
| Tax withholdings related to restricted and performance share vesting | (39,416) | (28,061) |
| Payment of finance lease liabilities | (2,761) | (2,523) |
| Payment of contingent consideration | (11,216) | (18,114) |
| Net cash used in financing activities | (2,041,941) | (20,379) |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | (535) | 625 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (1,909,375) | 275,827 |
| Cash, cash equivalents, and restricted cash at beginning of period | 3,215,221 | 2,953,120 |
| Cash, cash equivalents, and restricted cash at end of period | $1,305,846 | $3,228,947 |
| Supplemental Schedule of Cash Flow Information | ||
| Income taxes paid | $302,860 | $253,180 |
| Unpaid purchases of property and equipment | $3,538 | $11 |
| Unpaid excise tax on repurchase of common stock | $19,185 | $— |
| Leased assets obtained in exchange for new operating lease liabilities | $2,436 | $5,275 |
| Leased assets obtained in exchange for new finance lease liabilities | $1,959 | $1,176 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.